These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10370548)

  • 21. The use of intravenous immunoglobulins: recommendations of a consensus conference of the working group of immunology of the Italian Society of Pediatrics.
    Ann Allergy; 1989 Apr; 62(4):362-7. PubMed ID: 2495747
    [No Abstract]   [Full Text] [Related]  

  • 22. [Old and current aspects of intravenous immunoglobulin therapy].
    Nydegger U
    Schweiz Med Wochenschr; 1994 Jan; 124(1-2):5-25. PubMed ID: 8296191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous immunoglobulin as clinical immune-modulating therapy.
    Gilardin L; Bayry J; Kaveri SV
    CMAJ; 2015 Mar; 187(4):257-264. PubMed ID: 25667260
    [No Abstract]   [Full Text] [Related]  

  • 24. The pocketbook: Pharmacoeconomic issues related to intravenous immunoglobulin therapy.
    Mahadevia PJ
    Pharmacotherapy; 2005 Nov; 25(11 Pt 2):94S-100S. PubMed ID: 16229680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kawasaki disease in Calcutta.
    Paul DK; Gupta A; Lahiri M
    Indian Pediatr; 2000 Nov; 37(11):1264-5. PubMed ID: 11086312
    [No Abstract]   [Full Text] [Related]  

  • 26. Neurologic complications of treatment of childhood acute immune thrombocytopenic purpura with intravenously administered immunoglobulin G.
    Kattamis AC; Shankar S; Cohen AR
    J Pediatr; 1997 Feb; 130(2):281-3. PubMed ID: 9042132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous immunoglobulin: more questions than answers.
    Blanchette VS; Sacher RA
    Transfus Med Rev; 1991 Jul; 5(3):165-70. PubMed ID: 1821177
    [No Abstract]   [Full Text] [Related]  

  • 28. How far should we go with cost-utility analysis when treating children with acute idiopathic thrombocytopenic purpura?
    Benesch M
    Pediatr Blood Cancer; 2008 Feb; 50(2):433. PubMed ID: 17458876
    [No Abstract]   [Full Text] [Related]  

  • 29. Intravenous immune globulin and aseptic meningitis.
    Rao SP; Teitlebaum J; Miller ST
    Am J Dis Child; 1992 May; 146(5):539-40. PubMed ID: 1306046
    [No Abstract]   [Full Text] [Related]  

  • 30. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies.
    Dams ET; van der Meer JW
    Lancet; 1995 Apr; 345(8953):864. PubMed ID: 7898254
    [No Abstract]   [Full Text] [Related]  

  • 31. Supply, use, and abuse of intravenous immunoglobulin.
    Nowak-Wegrzyn A; Lederman HM
    Curr Opin Pediatr; 1999 Dec; 11(6):533-9. PubMed ID: 10590912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous immunoglobulin or megadose methylprednisolone for the treatment of idiopathic thrombocytopenic purpura.
    Ozsoylu S
    Am J Pediatr Hematol Oncol; 1991; 13(3):364-5. PubMed ID: 1817495
    [No Abstract]   [Full Text] [Related]  

  • 33. Idiopathic thrombocytopenia purpura: Treatment patterns and an analysis of cost associated with intravenous immunoglobulin and anti-D therapy.
    Simpson KN; Coughlin CM; Eron J; Bussel JB
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):58-64. PubMed ID: 9523750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune (idiopathic) thrombocytopenic purpura.
    Hauser S
    Lancet; 1997 Aug; 350(9074):368. PubMed ID: 9251663
    [No Abstract]   [Full Text] [Related]  

  • 35. Aseptic meningitis due to administration of intravenous immunoglobulin with an unusually high number of leukocytes in cerebrospinal fluid.
    Obando I; Duran I; Martin-Rosa L; Cano JM; Garcia-Martin FJ
    Pediatr Emerg Care; 2002 Dec; 18(6):429-32. PubMed ID: 12488836
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunoglobulins in Hematology. Immunologic thrombopenic purpura].
    Zini JM; Tobelem G
    Ann Med Interne (Paris); 1993; 144(8):514-7. PubMed ID: 8179239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of childhood immune thrombocytopenic purpura.
    Lilleyman JS
    Lancet; 1994 Oct; 344(8930):1155. PubMed ID: 7934509
    [No Abstract]   [Full Text] [Related]  

  • 38. [Polyvalent intravenous immunoglobulins: their use in dermatology].
    Derancourt C; Humbert P; Agache P
    Ann Dermatol Venereol; 1992; 119(6-7):487-8. PubMed ID: 1444110
    [No Abstract]   [Full Text] [Related]  

  • 39. [Present status of high-dose intravenous immunoglobulin therapy and the future prospects ].
    Kawasugi K
    Nihon Rinsho Meneki Gakkai Kaishi; 2003 Jun; 26(3):87-95. PubMed ID: 12868126
    [No Abstract]   [Full Text] [Related]  

  • 40. Intravenous immunoglobulin in rheumatic disease.
    Klassen LW; Calabrese LH; Laxer RM
    Rheum Dis Clin North Am; 1996 Feb; 22(1):155-73. PubMed ID: 8907070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.